UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
We summarize typical holdings and how index funds achieve broad market exposure with a defined set of constituents.
14,909 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Senior executives are increasingly deferring about $100,000 of pay into non-qualified plans to extend tax-advantaged ...
XRP spot ETFs have attracted $1.39 billion since their late-2025 debut, beating Solana ETFs at $1.12 billion. The tre...
Through mid-May 2026, VXUS has risen about 10% year-to-date, narrowly surpassing the S&P 500’s roughly 8% gain. The m...
NextEra Energy is set to buy Dominion Energy in a $67 billion all-stock deal aimed at securing power capacity for AI-...
SpaceX plans a June IPO that would place a second Musk-led company in the public eye, raising questions about how muc...
Retirees facing rising taxes must plan withdrawals carefully. With $2M in retirement accounts, a strategic advisor ca...
A renewed debate over gifting beyond required minimum distributions challenges retirees to balance tax costs with lon...
Bitcoin, Ethereum, and XRP led a weekend comeback, lifting the total crypto market cap and centering attention on a p...
Bitcoin price stabilizes $77k after weekend volatility, as President Trump updates on Iran talks. Markets enter a cal...
When a major tech name drops, many investors feel the urge to retreat. Yet history shows that this tech stock down mo...
Marvell Technology shares surprised investors with a notable intraday uptick amid improving sentiment for semiconduct...